Compliance Policy

SolRUO does not opine on the regulatory status of any specific compound. The platform is designed to support distributors whose products are sold strictly for research use under 21 CFR §201.128 and whose storefronts comply with applicable federal and state law. SolRUO is not a law firm; nothing here is legal advice.

• Counterparty verification gate — every storefront visitor must verify qualified research counterparty status before viewing products.
• Signed intended-use attestation — every buyer signs a locked attestation aligned to 21 CFR §201.128 prior to checkout.
• Standardized RUO and FDA disclaimer wording — distributors cannot remove or weaken the required language.
• Tamper-evident audit record — counterparty type, intended use, timestamp, IP, and signature hash are cryptographically sealed per transaction.
• Weekly storefront compliance scan — automated detection of medical claims, human-use language, missing disclaimers, and drift.
• Jurisdiction enforcement — purchases from restricted jurisdictions are blocked at the verification layer.
• Exportable audit trail — distributors and SolRUO can produce a complete, signed audit record for processor review on demand.

Before activation, SolRUO confirms business entity and EIN, reviews the storefront against RUO standards, inspects labeling and CoA documentation, scans for prohibited health claims across pages, metadata, and reviews, and confirms jurisdiction eligibility. Distributors that do not pass review are not activated.

SolRUO runs an automated compliance scan on each connected storefront weekly and produces a compliance score with line-item findings. Distributors are responsible for remediation. Repeated unresolved findings, score deterioration, or any high-severity finding may trigger an account hold and processor notification.

SolRUO maintains documentation aligned to the preventive-measures standard processors reference for research-use merchants. SolRUO does not act as your representative to any processor; processor approval is determined independently. SolRUO will, however, produce the audit trail and policy documentation a processor reasonably requests.

SolRUO screens distributor entities and principals against OFAC and equivalent sanctions lists at onboarding and on a recurring basis. Distributors must promptly disclose changes in ownership, control, or beneficial ownership.

If SolRUO becomes aware of a material compliance incident, security incident, or processor-impacting event, we will notify affected distributors without undue delay and coordinate remediation. Reports may be sent to trust@solruo.com.

This policy is reviewed at least annually and updated as processor requirements, regulatory guidance, and platform capabilities evolve.